Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt

Diabetes mellitus (DM) is a common metabolic illness defined by hyperglycemia caused by insufficient production or absent of pancreatic insulin, with or without concomitant insulin action impairment. Hence, novel problem-solving approaches for assessing early metabolic diseases, notably insulin resi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioinformation 2021-11, Vol.17 (11), p.916-920
Hauptverfasser: Mani, Vadivel, Balraj, Manikandan, Venktsan, Gayathri, Soundrapandiyan, Jagatheesh, Kasthuri, Revathi, Danavel, Anandhi, Babu, Shyamaladevi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 920
container_issue 11
container_start_page 916
container_title Bioinformation
container_volume 17
creator Mani, Vadivel
Balraj, Manikandan
Venktsan, Gayathri
Soundrapandiyan, Jagatheesh
Kasthuri, Revathi
Danavel, Anandhi
Babu, Shyamaladevi
description Diabetes mellitus (DM) is a common metabolic illness defined by hyperglycemia caused by insufficient production or absent of pancreatic insulin, with or without concomitant insulin action impairment. Hence, novel problem-solving approaches for assessing early metabolic diseases, notably insulin resistance, are urgently needed. Screening of natural compounds for drug discovery to combat diabetes is common in modern medical research and development. Therefore, it is of interest to document the molecular docking analysis data of beta-Caryophyllene, a naturally occurring sequiterpene with the downstream insulin signaling molecules such as IRS-1, cSrc and Akt for the management of type-2 diabetes. The molecular docking analysis data of beta-caryophyllene with the insulin downstream signaling molecules such as IRS-1, cSrc and Akt reveals its ability and further studies are needed to elucidate its complete mechanism of action against type-2 diabetes.
doi_str_mv 10.6026/97320630017916
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9148591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2599635122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-87816aae18cc39a22b3b6d292cacbb3bcd51601e4ba351a82f77edb474b64e233</originalsourceid><addsrcrecordid>eNpdkc1LAzEQxYMotlavHmXBiwe35mM32VyEUvwoVASr55DNZttt001NdpX-96a0luopw8wvjzfzALhEsE8hpnecEQwpgRAxjugR6MLQiTet44O6A868n0OYIMbSU9AhKU1TjmAXjF6s0ao10kWFVYuqnkaylmbtKx_ZMsp1I2Ml3dquZmtjdK2j76qZRaO3SYxuIzVxKvBFNFg05-CklMbri93bAx-PD-_D53j8-jQaDsaxIknWxBnLEJVSo0wpwiXGOclpgTlWUuWhVkWKKEQ6ySVJkcxwyZgu8oQlOU00JqQH7re6qzZf6kLpunHSiJWrlsGnsLISfyd1NRNT-yU4SrKwdBC42Qk4-9lq34hl5ZU2Rtbatl5gykg4UHAb0Ot_6Ny2LtwnUCnnNDjEOFD9LaWc9d7pcm8GQbFJSfxNKXy4Olxhj__GQn4AIZCL4A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2599635122</pqid></control><display><type>article</type><title>Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Mani, Vadivel ; Balraj, Manikandan ; Venktsan, Gayathri ; Soundrapandiyan, Jagatheesh ; Kasthuri, Revathi ; Danavel, Anandhi ; Babu, Shyamaladevi</creator><creatorcontrib>Mani, Vadivel ; Balraj, Manikandan ; Venktsan, Gayathri ; Soundrapandiyan, Jagatheesh ; Kasthuri, Revathi ; Danavel, Anandhi ; Babu, Shyamaladevi ; Department of Biochemistry, Arunai Medical College &amp; Hospital, Tiruvanamallai-606603, Tamilnadu, India</creatorcontrib><description>Diabetes mellitus (DM) is a common metabolic illness defined by hyperglycemia caused by insufficient production or absent of pancreatic insulin, with or without concomitant insulin action impairment. Hence, novel problem-solving approaches for assessing early metabolic diseases, notably insulin resistance, are urgently needed. Screening of natural compounds for drug discovery to combat diabetes is common in modern medical research and development. Therefore, it is of interest to document the molecular docking analysis data of beta-Caryophyllene, a naturally occurring sequiterpene with the downstream insulin signaling molecules such as IRS-1, cSrc and Akt for the management of type-2 diabetes. The molecular docking analysis data of beta-caryophyllene with the insulin downstream signaling molecules such as IRS-1, cSrc and Akt reveals its ability and further studies are needed to elucidate its complete mechanism of action against type-2 diabetes.</description><identifier>ISSN: 0973-2063</identifier><identifier>ISSN: 0973-8894</identifier><identifier>EISSN: 0973-2063</identifier><identifier>DOI: 10.6026/97320630017916</identifier><identifier>PMID: 35655910</identifier><language>eng</language><publisher>Singapore: Biomedical Informatics</publisher><subject>AKT protein ; Caryophyllene ; Data analysis ; Diabetes ; Diabetes mellitus ; Hyperglycemia ; Insulin ; Insulin receptor substrate 1 ; Insulin resistance ; Medical research ; Metabolic disorders ; Metabolism ; Molecular docking ; Problem solving ; R&amp;D ; Research &amp; development ; Signaling</subject><ispartof>Bioinformation, 2021-11, Vol.17 (11), p.916-920</ispartof><rights>2021 Biomedical Informatics.</rights><rights>Copyright Biomedical Informatics Nov 2021</rights><rights>2021 Biomedical Informatics 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-87816aae18cc39a22b3b6d292cacbb3bcd51601e4ba351a82f77edb474b64e233</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148591/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148591/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35655910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mani, Vadivel</creatorcontrib><creatorcontrib>Balraj, Manikandan</creatorcontrib><creatorcontrib>Venktsan, Gayathri</creatorcontrib><creatorcontrib>Soundrapandiyan, Jagatheesh</creatorcontrib><creatorcontrib>Kasthuri, Revathi</creatorcontrib><creatorcontrib>Danavel, Anandhi</creatorcontrib><creatorcontrib>Babu, Shyamaladevi</creatorcontrib><creatorcontrib>Department of Biochemistry, Arunai Medical College &amp; Hospital, Tiruvanamallai-606603, Tamilnadu, India</creatorcontrib><title>Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt</title><title>Bioinformation</title><addtitle>Bioinformation</addtitle><description>Diabetes mellitus (DM) is a common metabolic illness defined by hyperglycemia caused by insufficient production or absent of pancreatic insulin, with or without concomitant insulin action impairment. Hence, novel problem-solving approaches for assessing early metabolic diseases, notably insulin resistance, are urgently needed. Screening of natural compounds for drug discovery to combat diabetes is common in modern medical research and development. Therefore, it is of interest to document the molecular docking analysis data of beta-Caryophyllene, a naturally occurring sequiterpene with the downstream insulin signaling molecules such as IRS-1, cSrc and Akt for the management of type-2 diabetes. The molecular docking analysis data of beta-caryophyllene with the insulin downstream signaling molecules such as IRS-1, cSrc and Akt reveals its ability and further studies are needed to elucidate its complete mechanism of action against type-2 diabetes.</description><subject>AKT protein</subject><subject>Caryophyllene</subject><subject>Data analysis</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Hyperglycemia</subject><subject>Insulin</subject><subject>Insulin receptor substrate 1</subject><subject>Insulin resistance</subject><subject>Medical research</subject><subject>Metabolic disorders</subject><subject>Metabolism</subject><subject>Molecular docking</subject><subject>Problem solving</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Signaling</subject><issn>0973-2063</issn><issn>0973-8894</issn><issn>0973-2063</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpdkc1LAzEQxYMotlavHmXBiwe35mM32VyEUvwoVASr55DNZttt001NdpX-96a0luopw8wvjzfzALhEsE8hpnecEQwpgRAxjugR6MLQiTet44O6A868n0OYIMbSU9AhKU1TjmAXjF6s0ao10kWFVYuqnkaylmbtKx_ZMsp1I2Ml3dquZmtjdK2j76qZRaO3SYxuIzVxKvBFNFg05-CklMbri93bAx-PD-_D53j8-jQaDsaxIknWxBnLEJVSo0wpwiXGOclpgTlWUuWhVkWKKEQ6ySVJkcxwyZgu8oQlOU00JqQH7re6qzZf6kLpunHSiJWrlsGnsLISfyd1NRNT-yU4SrKwdBC42Qk4-9lq34hl5ZU2Rtbatl5gykg4UHAb0Ot_6Ny2LtwnUCnnNDjEOFD9LaWc9d7pcm8GQbFJSfxNKXy4Olxhj__GQn4AIZCL4A</recordid><startdate>20211130</startdate><enddate>20211130</enddate><creator>Mani, Vadivel</creator><creator>Balraj, Manikandan</creator><creator>Venktsan, Gayathri</creator><creator>Soundrapandiyan, Jagatheesh</creator><creator>Kasthuri, Revathi</creator><creator>Danavel, Anandhi</creator><creator>Babu, Shyamaladevi</creator><general>Biomedical Informatics</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211130</creationdate><title>Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt</title><author>Mani, Vadivel ; Balraj, Manikandan ; Venktsan, Gayathri ; Soundrapandiyan, Jagatheesh ; Kasthuri, Revathi ; Danavel, Anandhi ; Babu, Shyamaladevi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-87816aae18cc39a22b3b6d292cacbb3bcd51601e4ba351a82f77edb474b64e233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>AKT protein</topic><topic>Caryophyllene</topic><topic>Data analysis</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Hyperglycemia</topic><topic>Insulin</topic><topic>Insulin receptor substrate 1</topic><topic>Insulin resistance</topic><topic>Medical research</topic><topic>Metabolic disorders</topic><topic>Metabolism</topic><topic>Molecular docking</topic><topic>Problem solving</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Signaling</topic><toplevel>online_resources</toplevel><creatorcontrib>Mani, Vadivel</creatorcontrib><creatorcontrib>Balraj, Manikandan</creatorcontrib><creatorcontrib>Venktsan, Gayathri</creatorcontrib><creatorcontrib>Soundrapandiyan, Jagatheesh</creatorcontrib><creatorcontrib>Kasthuri, Revathi</creatorcontrib><creatorcontrib>Danavel, Anandhi</creatorcontrib><creatorcontrib>Babu, Shyamaladevi</creatorcontrib><creatorcontrib>Department of Biochemistry, Arunai Medical College &amp; Hospital, Tiruvanamallai-606603, Tamilnadu, India</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bioinformation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mani, Vadivel</au><au>Balraj, Manikandan</au><au>Venktsan, Gayathri</au><au>Soundrapandiyan, Jagatheesh</au><au>Kasthuri, Revathi</au><au>Danavel, Anandhi</au><au>Babu, Shyamaladevi</au><aucorp>Department of Biochemistry, Arunai Medical College &amp; Hospital, Tiruvanamallai-606603, Tamilnadu, India</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt</atitle><jtitle>Bioinformation</jtitle><addtitle>Bioinformation</addtitle><date>2021-11-30</date><risdate>2021</risdate><volume>17</volume><issue>11</issue><spage>916</spage><epage>920</epage><pages>916-920</pages><issn>0973-2063</issn><issn>0973-8894</issn><eissn>0973-2063</eissn><abstract>Diabetes mellitus (DM) is a common metabolic illness defined by hyperglycemia caused by insufficient production or absent of pancreatic insulin, with or without concomitant insulin action impairment. Hence, novel problem-solving approaches for assessing early metabolic diseases, notably insulin resistance, are urgently needed. Screening of natural compounds for drug discovery to combat diabetes is common in modern medical research and development. Therefore, it is of interest to document the molecular docking analysis data of beta-Caryophyllene, a naturally occurring sequiterpene with the downstream insulin signaling molecules such as IRS-1, cSrc and Akt for the management of type-2 diabetes. The molecular docking analysis data of beta-caryophyllene with the insulin downstream signaling molecules such as IRS-1, cSrc and Akt reveals its ability and further studies are needed to elucidate its complete mechanism of action against type-2 diabetes.</abstract><cop>Singapore</cop><pub>Biomedical Informatics</pub><pmid>35655910</pmid><doi>10.6026/97320630017916</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0973-2063
ispartof Bioinformation, 2021-11, Vol.17 (11), p.916-920
issn 0973-2063
0973-8894
0973-2063
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9148591
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects AKT protein
Caryophyllene
Data analysis
Diabetes
Diabetes mellitus
Hyperglycemia
Insulin
Insulin receptor substrate 1
Insulin resistance
Medical research
Metabolic disorders
Metabolism
Molecular docking
Problem solving
R&D
Research & development
Signaling
title Molecular docking analysis of beta-caryophyllene with IRS-1, cSrc and Akt
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A20%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20docking%20analysis%20of%20beta-caryophyllene%20with%20IRS-1,%20cSrc%20and%20Akt&rft.jtitle=Bioinformation&rft.au=Mani,%20Vadivel&rft.aucorp=Department%20of%20Biochemistry,%20Arunai%20Medical%20College%20&%20Hospital,%20Tiruvanamallai-606603,%20Tamilnadu,%20India&rft.date=2021-11-30&rft.volume=17&rft.issue=11&rft.spage=916&rft.epage=920&rft.pages=916-920&rft.issn=0973-2063&rft.eissn=0973-2063&rft_id=info:doi/10.6026/97320630017916&rft_dat=%3Cproquest_pubme%3E2599635122%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2599635122&rft_id=info:pmid/35655910&rfr_iscdi=true